D-Kimia Overview

  • Founded
  • 2013
  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

D-Kimia General Information


Developer of a technology designed to detect a broad range of diseases by targeting the nucleic acid signature of the disease. The company's technology develops diagnostic tests that utilize gold nano particles to detect specific nucleic acid sequences, enabling patients suffering from diseases such as Hepatitis C to avail cheaper and simpler approach to help control the disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Services
Primary Office
  • 67 Abdelaziz Al Saud Street
  • Cairo Egypt
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

D-Kimia Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Generating Revenue
To view D-Kimia’s complete valuation and funding history, request access »

D-Kimia Executive Team (2)

Name Title Board Seat Contact Info
Karim Hussein Chief Executive Officer & Co-Founder
Hassan Azzazy Co-Founder, President & Chief Science Officer
To view D-Kimia’s complete executive team members history, request access »

D-Kimia Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AUC Venture Lab Accelerator/Incubator Minority 000 0000 000000 0
To view D-Kimia’s complete investors history, request access »